{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:27:18Z","timestamp":1787236038779,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68403-w","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T21:01:18Z","timestamp":1722114078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Optimizing the resveratrol fragments for novel in silico hepatocellular carcinoma de novo drug design"],"prefix":"10.1038","volume":"14","author":[{"given":"Muhammad","family":"Naveed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushbakht","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafiz Muzzammel","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metab","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah F.","family":"Alasmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,28]]},"reference":[{"issue":"3","key":"68403_CR1","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","volume":"5","author":"J Bruix","year":"2004","unstructured":"Bruix, J., Boix, L., Sala, M. & Llovet, J. M. Focus on hepatocellular carcinoma. Cancer Cell 5(3), 215\u2013219 (2004).","journal-title":"Cancer Cell"},{"key":"68403_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/JHC.S61146","volume":"3","author":"J Balogh","year":"2016","unstructured":"Balogh, J. et al. Hepatocellular carcinoma: A review. J. Hepatocell. Carcinoma 3, 41\u201353 (2016).","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"5","key":"68403_CR3","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.gastro.2004.09.018","volume":"127","author":"CY Mimi","year":"2004","unstructured":"Mimi, C. Y. & Yuan, J.-M. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127(5), S72\u2013S78 (2004).","journal-title":"Gastroenterology"},{"issue":"3","key":"68403_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1574362409666140206223014","volume":"8","author":"Z Bielecka","year":"2013","unstructured":"Bielecka, Z., Czarnecka, A., Solarek, W., Kornakiewicz, A. & Szczylik, C. Mechanisms of acquired resistance to tyrosine kinase inhibitors in clear-cell renal cell carcinoma (ccRCC). Curr. Signal Transduct. Ther. 8(3), 219\u2013228 (2013).","journal-title":"Curr. Signal Transduct. Ther."},{"key":"68403_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.actaastro.2017.04.020","volume":"137","author":"D Kashirina","year":"2017","unstructured":"Kashirina, D. et al. Effect of 21-day head down bed rest on urine proteins related to endothelium: Correlations with changes in carbohydrate metabolism. Acta Astronaut. 137, 122\u2013127 (2017).","journal-title":"Acta Astronaut."},{"key":"68403_CR6","doi-asserted-by":"publisher","first-page":"122437","DOI":"10.1016\/j.talanta.2021.122437","volume":"232","author":"H Yang","year":"2021","unstructured":"Yang, H., Xu, F., Chen, Y. & Tian, Z. Putative N-glycoprotein markers of MCF-7\/ADR cancer stem cells from N-glycoproteomics characterization of the whole cell lysate. Talanta 232, 122437 (2021).","journal-title":"Talanta"},{"issue":"6","key":"68403_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.21873\/cgp.20159","volume":"16","author":"YH Feng","year":"2019","unstructured":"Feng, Y. H., Tung, C. L., Su, Y. C., Tsao, C. J. & Wu, T. F. Proteomic profile of sorafenib resistance in hepatocellular carcinoma; GRP78 expression is associated with inferior response to sorafenib. Cancer Genom. Proteom. 16(6), 569\u2013576 (2019).","journal-title":"Cancer Genom. Proteom."},{"issue":"11","key":"68403_CR8","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/biomedicines9111639","volume":"9","author":"EJ Sun","year":"2021","unstructured":"Sun, E. J., Wankell, M., Palamuthusingam, P., McFarlane, C. & Hebbard, L. Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma. Biomedicines 9(11), 1639 (2021).","journal-title":"Biomedicines"},{"issue":"22","key":"68403_CR9","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.3390\/cancers13225753","volume":"13","author":"S Rodriguez","year":"2021","unstructured":"Rodriguez, S. et al. Phytochemicals as an alternative or integrative option, in conjunction with conventional treatments for hepatocellular carcinoma. Cancers 13(22), 5753 (2021).","journal-title":"Cancers"},{"key":"68403_CR10","doi-asserted-by":"publisher","first-page":"1039121","DOI":"10.3389\/fmolb.2022.1039121","volume":"9","author":"DC Guven","year":"2022","unstructured":"Guven, D. C. et al. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Front. Mol. Biosci. 9, 1039121. https:\/\/doi.org\/10.3389\/fmolb.2022.1039121 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"68403_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28337-6","author":"S De Lorenzo","year":"2018","unstructured":"De Lorenzo, S. et al. Metronomic capecitabine vs. best supportive care in child-pugh B hepatocellular carcinoma: A proof of concept. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-28337-6 (2018).","journal-title":"Sci. Rep."},{"issue":"6","key":"68403_CR12","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00262-023-03366-x","volume":"72","author":"A Rizzo","year":"2023","unstructured":"Rizzo, A. et al. Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: The MOUSEION-05 study. Cancer Immunol. Immunother. 72(6), 1381\u20131394. https:\/\/doi.org\/10.1007\/s00262-023-03366-x (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"68403_CR13","doi-asserted-by":"publisher","first-page":"11363","DOI":"10.3390\/ijms231911363","volume":"23","author":"A Rizzo","year":"2022","unstructured":"Rizzo, A. & Ricci, A. D. Challenges and future trends of hepatocellular carcinoma immunotherapy. Int. J. Mol. Sci. 23, 11363. https:\/\/doi.org\/10.3390\/ijms231911363 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"68403_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2217\/fon-2020-0986","volume":"17","author":"A Rizzo","year":"2021","unstructured":"Rizzo, A., Ricci, A. D. & Brandi, G. Immune-based combinations for advanced hepatocellular carcinoma: Shaping the direction of first-line therapy. Future Oncol. 17(7), 755\u2013757. https:\/\/doi.org\/10.2217\/fon-2020-0986 (2021).","journal-title":"Future Oncol."},{"issue":"32","key":"68403_CR15","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.2217\/fon-2020-0669","volume":"16","author":"A Rizzo","year":"2020","unstructured":"Rizzo, A., Ricci, A. D. & Brandi, G. Systemic adjuvant treatment in hepatocellular carcinoma: Tempted to do something rather than nothing. Future Oncol. 16(32), 2587\u20132589. https:\/\/doi.org\/10.2217\/fon-2020-0669 (2020).","journal-title":"Future Oncol."},{"issue":"12","key":"68403_CR16","first-page":"5530","volume":"27","author":"M Naveed","year":"2023","unstructured":"Naveed, M. et al. A pharmacophore screening approach of homeopathic phenols for a renovated design of fragment-optimized Bauhiniastatin-1 as a drug against acromegaly. Eur. Rev. Med. Pharmacol. Sci. 27(12), 5530\u20135541 (2023).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"W1","key":"68403_CR17","doi-asserted-by":"publisher","first-page":"W326","DOI":"10.1093\/nar\/gkab385","volume":"49","author":"L Pinzi","year":"2021","unstructured":"Pinzi, L., Tinivella, A., Gagliardelli, L., Beneventano, D. & Rastelli, G. LigAdvisor: A versatile and user-friendly web-platform for drug design. Nucleic Acids Res. 49(W1), W326\u2013W335 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"68403_CR18","first-page":"1","volume":"1","author":"JG Meyer","year":"2021","unstructured":"Meyer, J. G. Deep learning neural network tools for proteomics. Cell Rep. Methods 1(2), 1\u201310 (2021).","journal-title":"Cell Rep. Methods"},{"issue":"4","key":"68403_CR19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/biomedicines11041041","volume":"11","author":"M Naveed","year":"2023","unstructured":"Naveed, M. et al. Artificial intelligence assisted pharmacophore design for philadelphia chromosome-positive leukemia with gamma-tocotrienol: A toxicity comparison approach with asciminib. Biomedicines 11(4), 1041 (2023).","journal-title":"Biomedicines"},{"issue":"5","key":"68403_CR20","doi-asserted-by":"publisher","first-page":"bbac337","DOI":"10.1093\/bib\/bbac337","volume":"23","author":"AG de S\u00e1","year":"2022","unstructured":"de S\u00e1, A. G., Long, Y., Portelli, S., Pires, D. E. & Ascher, D. B. toxCSM: Comprehensive prediction of small molecule toxicity profiles. Brief. Bioinform. 23(5), bbac337 (2022).","journal-title":"Brief. Bioinform."},{"key":"68403_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2269-7_19","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan, S. & Olson, A. J. Small-molecule library screening by docking with PyRx. Chem. Biol. Methods Protoc. https:\/\/doi.org\/10.1007\/978-1-4939-2269-7_19 (2015).","journal-title":"Chem. Biol. Methods Protoc."},{"key":"68403_CR22","doi-asserted-by":"publisher","DOI":"10.1063\/14764089","author":"RE Isele-Holder","year":"2012","unstructured":"Isele-Holder, R. E., Mitchell, W. & Ismail, A. E. Development and application of a particle-particle particle-mesh Ewald method for dispersion interactions. J. Chem. Phys. https:\/\/doi.org\/10.1063\/14764089 (2012).","journal-title":"J. Chem. Phys."},{"key":"68403_CR23","doi-asserted-by":"publisher","DOI":"10.1063\/14811291","author":"J Armstrong","year":"2013","unstructured":"Armstrong, J. & Bresme, F. Water polarization induced by thermal gradients: The extended simple point charge model (SPC\/E). J. Chem. Phys. https:\/\/doi.org\/10.1063\/14811291 (2013).","journal-title":"J. Chem. Phys."},{"issue":"1","key":"68403_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/jcph.1998.6171","volume":"151","author":"SD Bond","year":"1999","unstructured":"Bond, S. D., Leimkuhler, B. J. & Laird, B. B. The nos\u00e9-poincar\u00e9 method for constant temperature molecular dynamics. J. Computat. Phys. 151(1), 114\u2013134 (1999).","journal-title":"J. Computat. Phys."},{"key":"68403_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn, K. A., Petrick, J. L. & El-Serag, H. B. Epidemiology of hepatocellular carcinoma. Hepatology 73, 4\u201313 (2021).","journal-title":"Hepatology"},{"issue":"1","key":"68403_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/toxsci\/kfad015","volume":"192","author":"S-E Ali","year":"2023","unstructured":"Ali, S.-E. et al. Identification of flucloxacillin-modified hepatocellular proteins: Implications in flucloxacillin-induced liver injury. Toxicol. Sci. 192(1), 106\u2013116 (2023).","journal-title":"Toxicol. Sci."},{"key":"68403_CR27","doi-asserted-by":"publisher","first-page":"1136779","DOI":"10.3389\/fphar.2023.1136779","volume":"14","author":"A Dogra","year":"2023","unstructured":"Dogra, A. & Kumar, J. Biosynthesis of anticancer phytochemical compounds and their chemistry. Front. Pharmacol. 14, 1136779 (2023).","journal-title":"Front. Pharmacol."},{"issue":"2","key":"68403_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/2213346110666230517114652","volume":"10","author":"S Saidul","year":"2023","unstructured":"Saidul, S., Das, S. & Hoda, M. Evaluation of nonconventional extraction methods of resveratrol from various plant sources\u2014A brief review. Curr. Green Chem. 10(2), 131\u2013142 (2023).","journal-title":"Curr. Green Chem."},{"issue":"18","key":"68403_CR29","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.3390\/cancers15184563","volume":"15","author":"A Czerwonka","year":"2023","unstructured":"Czerwonka, A., Ka\u0142afut, J. & Nees, M. Modulation of notch signaling by small-molecular compounds and its potential in anticancer studies. Cancers 15(18), 4563 (2023).","journal-title":"Cancers"},{"issue":"1","key":"68403_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/bioengineering10010011","volume":"10","author":"M Naveed","year":"2023","unstructured":"Naveed, M. et al. Chain-engineering-based de novo drug design against MPXVgp169 virulent protein of monkeypox virus: A molecular modification approach. Bioengineering 10(1), 11 (2023).","journal-title":"Bioengineering"},{"key":"68403_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2024.2316762","author":"I Fatima","year":"2024","unstructured":"Fatima, I. et al. Revolutionizing and identifying novel drug targets in Citrobacter koseri via subtractive proteomics and development of a multi-epitope vaccine using reverse vaccinology and immuno-informatics. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2024.2316762 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"68403_CR32","doi-asserted-by":"publisher","first-page":"20230197","DOI":"10.1515\/chem-2023-0197","volume":"22","author":"M Naveed","year":"2024","unstructured":"Naveed, M. et al. Comparative toxicity assessment of fisetin-aided artificial intelligence-assisted drug design targeting epibulbar dermoid through phytochemicals. Open Chem. 22(1), 20230197. https:\/\/doi.org\/10.1515\/chem-2023-0197 (2024).","journal-title":"Open Chem."}],"updated-by":[{"DOI":"10.1038\/s41598-024-70043-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68403-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68403-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68403-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T14:07:28Z","timestamp":1724162848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68403-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68403"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68403-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,28]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-024-70043-z","URL":"https:\/\/doi.org\/10.1038\/s41598-024-70043-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17336"}}